Cetuximab Biosimilar - GAALIE Research Grade,ichor.bio,ICH4004Fc

Detects human EGFR.

Host

CHO Cells

Reactivity

Human

Platform ID

BAB197570621

ichor.bio

Headquarters

Grove Business Park Downsview Road Wantage OX12 9FF

ichor.bio

Contact

Tel:
Fax:

Email:

[email protected]

Product Specifications
Scientific Background
Synonyms

Specifications

NameCetuximab Biosimilar - GAALIE Research Grade
Cat. No.ICH4004Fc
Accession NumberP00533
HostCHO Cells
IsotypeHuman IgG1 (Mutation)-kappa
ReactivityHuman
Concentration5mg/ml
TargetEGFR
Purity>95% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml ICH3002-100ml ICH3003-100ml
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only

Scientific Background

GAALIE mutations increase the affinity binding of IgG1 to the Fc activating receptors.

Synonyms

Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.